TARDBP and neoplasm: However, it is possible that RA may cause toxicity effect on the immune cells in TME owing to the wide distributed TDP‐43, hence, targeting delivery of RA to tumor site by nanoparticles or antibody‐drug conjugate strategies would help to elucidate this issue.